Ensaculin

• Description :

  Ensaculin is an NMDA receptor channel blocker. Ensaculin has neuroprotective effects in NMDA toxicity models and promotes neuronal growth in primary cultures of rat brain cells. Ensaculin has the potential to be developed as an anti-dementia drug that acts on various neurotransmitter systems[1].

• Product Name Alternative :

  KA-672 (hydrochloride) ; Anseculin (hydrochloride)

• UNSPSC :

  12352005

• Target :

  IGluR

• Type :

  Reference compound

• Related Pathways :

  Membrane Transporter/Ion Channel; Neuronal Signaling

• Applications :

  Neuroscience-Neurodegeneration

• Field of Research :

  Neurological Disease

• Assay Protocol :

  https://www.medchemexpress.com/ensaculin.html

• Smiles :

  O=C1C(C)=C(C)C2=CC(OCCCN3CCN(C4=CC=CC=C4OC)CC3)=C(OC)C=C2O1.[H]Cl

• Molecular Formula :

  C26H33ClN2O5

• Molecular Weight :

  489.00

• References & Citations :

  [1]Hoerr R, et al. Ensaculin (KA-672 HCl) : a multitransmitter approach to dementia treatment. CNS Drug Rev. 2002 Summer;8 (2) :143-58.

• Shipping Conditions :

  Room temperature

• Scientific Category :

  Reference compound1

• Clinical Information :

  No Development Reported

• CAS Number :

  [209969-60-8]